Canada
· Delayed Price · Currency is CAD Entourage Health Statistics
Total Valuation
TSXV:ENTG has a market cap or net worth of CAD 1.54 million. The enterprise value is 179.83 million.
| Market Cap | 1.54M |
| Enterprise Value | 179.83M |
Important Dates
The last earnings date was Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:ENTG has 308.39 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 308.39M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 19.57% |
| Float | 306.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.26 |
| EV / Sales | 4.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -29.89 |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -30.22 |
| Interest Coverage | -0.58 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -30.93% |
| Return on Invested Capital (ROIC) | -56.36% |
| Return on Capital Employed (ROCE) | 9.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 212 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 2.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 1.81, so TSXV:ENTG's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 44.26 |
| Average Volume (20 Days) | 162,251 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:ENTG had revenue of CAD 41.46 million and -42.16 million in losses. Loss per share was -0.14.
| Revenue | 41.46M |
| Gross Profit | 4.23M |
| Operating Income | -15.71M |
| Pretax Income | -42.16M |
| Net Income | -42.16M |
| EBITDA | -15.07M |
| EBIT | -15.71M |
| Loss Per Share | -0.14 |
Balance Sheet
The company has 3.52 million in cash and 181.81 million in debt, giving a net cash position of -178.29 million or -0.58 per share.
| Cash & Cash Equivalents | 3.52M |
| Total Debt | 181.81M |
| Net Cash | -178.29M |
| Net Cash Per Share | -0.58 |
| Equity (Book Value) | -172.21M |
| Book Value Per Share | -0.56 |
| Working Capital | -171.38M |
Cash Flow
In the last 12 months, operating cash flow was -5.39 million and capital expenditures -631,408, giving a free cash flow of -6.02 million.
| Operating Cash Flow | -5.39M |
| Capital Expenditures | -631,408 |
| Free Cash Flow | -6.02M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 10.21%, with operating and profit margins of -37.88% and -101.69%.
| Gross Margin | 10.21% |
| Operating Margin | -37.88% |
| Pretax Margin | -101.69% |
| Profit Margin | -101.69% |
| EBITDA Margin | -36.34% |
| EBIT Margin | -37.88% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:ENTG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | -0.39% |
| Earnings Yield | -2,734.55% |
| FCF Yield | -390.19% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:ENTG has an Altman Z-Score of -30.9. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -30.9 |
| Piotroski F-Score | n/a |